90 related articles for article (PubMed ID: 27343979)
1. Inhibitions of mTORC1 and 4EBP-1 are key events orchestrated by Rottlerin in SK-Mel-28 cell killing.
Daveri E; Maellaro E; Valacchi G; Ietta F; Muscettola M; Maioli E
Cancer Lett; 2016 Sep; 380(1):106-13. PubMed ID: 27343979
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation-independent mTORC1 inhibition by the autophagy inducer Rottlerin.
Torricelli C; Daveri E; Salvadori S; Valacchi G; Ietta F; Muscettola M; Carlucci F; Maioli E
Cancer Lett; 2015 Apr; 360(1):17-27. PubMed ID: 25661734
[TBL] [Abstract][Full Text] [Related]
3. Rottlerin induces autophagy and apoptosis in prostate cancer stem cells via PI3K/Akt/mTOR signaling pathway.
Kumar D; Shankar S; Srivastava RK
Cancer Lett; 2014 Feb; 343(2):179-89. PubMed ID: 24125861
[TBL] [Abstract][Full Text] [Related]
4. Rottlerin induces Wnt co-receptor LRP6 degradation and suppresses both Wnt/β-catenin and mTORC1 signaling in prostate and breast cancer cells.
Lu W; Lin C; Li Y
Cell Signal; 2014 Jun; 26(6):1303-9. PubMed ID: 24607787
[TBL] [Abstract][Full Text] [Related]
5. Rottlerin promotes autophagy and apoptosis in gastric cancer cell lines.
Song J; Zhou Y; Gong Y; Liu H; Tang L
Mol Med Rep; 2018 Sep; 18(3):2905-2913. PubMed ID: 30015872
[TBL] [Abstract][Full Text] [Related]
6. Screen for chemical modulators of autophagy reveals novel therapeutic inhibitors of mTORC1 signaling.
Balgi AD; Fonseca BD; Donohue E; Tsang TC; Lajoie P; Proud CG; Nabi IR; Roberge M
PLoS One; 2009 Sep; 4(9):e7124. PubMed ID: 19771169
[TBL] [Abstract][Full Text] [Related]
7. Multiple mechanisms of Rottlerin toxicity in A375 melanoma cells.
Ietta F; Valacchi G; Benincasa L; Pecorelli A; Cresti L; Maioli E
Biofactors; 2019 Nov; 45(6):920-929. PubMed ID: 31408224
[TBL] [Abstract][Full Text] [Related]
8. Ethambutol induces impaired autophagic flux and apoptosis in the rat retina.
Huang SP; Chien JY; Tsai RK
Dis Model Mech; 2015 Aug; 8(8):977-87. PubMed ID: 26092127
[TBL] [Abstract][Full Text] [Related]
9. Rottlerin induces autophagy and apoptotic cell death through a PKC-delta-independent pathway in HT1080 human fibrosarcoma cells: the protective role of autophagy in apoptosis.
Song KS; Kim JS; Yun EJ; Kim YR; Seo KS; Park JH; Jung YJ; Park JI; Kweon GR; Yoon WH; Lim K; Hwang BD
Autophagy; 2008 Jul; 4(5):650-8. PubMed ID: 18424913
[TBL] [Abstract][Full Text] [Related]
10. Pro-apoptotic and pro-autophagic effects of the Aurora kinase A inhibitor alisertib (MLN8237) on human osteosarcoma U-2 OS and MG-63 cells through the activation of mitochondria-mediated pathway and inhibition of p38 MAPK/PI3K/Akt/mTOR signaling pathway.
Niu NK; Wang ZL; Pan ST; Ding HQ; Au GH; He ZX; Zhou ZW; Xiao G; Yang YX; Zhang X; Yang T; Chen XW; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1555-84. PubMed ID: 25792811
[TBL] [Abstract][Full Text] [Related]
11. Cycloheximide inhibits starvation-induced autophagy through mTORC1 activation.
Watanabe-Asano T; Kuma A; Mizushima N
Biochem Biophys Res Commun; 2014 Mar; 445(2):334-9. PubMed ID: 24525133
[TBL] [Abstract][Full Text] [Related]
12. Two widely used RSK inhibitors, BI-D1870 and SL0101, alter mTORC1 signaling in a RSK-independent manner.
Roffé M; Lupinacci FC; Soares LC; Hajj GN; Martins VR
Cell Signal; 2015 Aug; 27(8):1630-42. PubMed ID: 25889895
[TBL] [Abstract][Full Text] [Related]
13. Non-conventional rottlerin anticancer properties.
Maioli E; Daveri E; Maellaro E; Ietta F; Cresti L; Valacchi G
Arch Biochem Biophys; 2018 May; 645():50-53. PubMed ID: 29545132
[TBL] [Abstract][Full Text] [Related]
14. Implication of integrin α2β1 in senescence of SK-Mel-147 human melanoma cells.
Kozlova NI; Morozevich GE; Berman AE
Aging (Albany NY); 2021 Jul; 13(14):18006-18017. PubMed ID: 34257160
[TBL] [Abstract][Full Text] [Related]
15. Rottlerin-mediated inhibition of Toxoplasma gondii growth in BeWo trophoblast-like cells.
Ietta F; Maioli E; Daveri E; Gonzaga Oliveira J; da Silva RJ; Romagnoli R; Cresti L; Maria Avanzati A; Paulesu L; Barbosa BF; Gomes AO; Roberto Mineo J; Ferro EAV
Sci Rep; 2017 Apr; 7(1):1279. PubMed ID: 28455500
[TBL] [Abstract][Full Text] [Related]
16. VS-5584, a Novel PI3K-mTOR Dual Inhibitor, Inhibits Melanoma Cell Growth In Vitro and In Vivo.
Shao Z; Bao Q; Jiang F; Qian H; Fang Q; Hu X
PLoS One; 2015; 10(7):e0132655. PubMed ID: 26204252
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of mitotic Aurora kinase A by alisertib induces apoptosis and autophagy of human gastric cancer AGS and NCI-N78 cells.
Yuan CX; Zhou ZW; Yang YX; He ZX; Zhang X; Wang D; Yang T; Wang NJ; Zhao RJ; Zhou SF
Drug Des Devel Ther; 2015; 9():487-508. PubMed ID: 25609923
[TBL] [Abstract][Full Text] [Related]
18. The PtdIns3-phosphatase MTMR3 interacts with mTORC1 and suppresses its activity.
Hao F; Itoh T; Morita E; Shirahama-Noda K; Yoshimori T; Noda T
FEBS Lett; 2016 Jan; 590(1):161-73. PubMed ID: 26787466
[TBL] [Abstract][Full Text] [Related]
19. Effects of sorafenib on energy metabolism in breast cancer cells: role of AMPK-mTORC1 signaling.
Fumarola C; Caffarra C; La Monica S; Galetti M; Alfieri RR; Cavazzoni A; Galvani E; Generali D; Petronini PG; Bonelli MA
Breast Cancer Res Treat; 2013 Aug; 141(1):67-78. PubMed ID: 23963659
[TBL] [Abstract][Full Text] [Related]
20. Resveratrol directly targets DDX5 resulting in suppression of the mTORC1 pathway in prostate cancer.
Taniguchi T; Iizumi Y; Watanabe M; Masuda M; Morita M; Aono Y; Toriyama S; Oishi M; Goi W; Sakai T
Cell Death Dis; 2016 May; 7(5):e2211. PubMed ID: 27148684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
